CONCLUSION: Findings provide preliminary support for a potential relationship between stimulant medication and reduced LOC-E and associated symptoms in youth with ADHD and comorbid LOC-E. Results mostly align with prior adult studies evaluating lisdexamfetamine for binge-eating disorder. Larger, controlled trials are needed to confirm these findings and investigate neurocognitive mechanisms. This study offers early evidence to inform future pharmacological approaches to treat ADHD and LOC-E in…
